Innovations accelerate growth of Dr. Wolff Group

Read more

In the first half of the year, the Dr. Wolff Group was able to increase sales by 6 percent compared to the same period of the previous year. “We currently expect further growth above average for the remainder of the year, so that we should reach sales of 400 million euros by the end of the year as planned,” Managing Partner Eduard R. Dörrenberg predicts.

The recent successful launch of the Alpecin Grey Attack Caffeine & Color Shampoo is expected to contribute to overall growth. In addition to caffeine as well-established active ingredient for strong hair, this innovative shampoo contains a novel and patent-pending color complex darkening gray hair gradually in the long term with the help of an oxygen reaction after daily shampooing. “The scientific data from studies published beforehand were already promising. This product launch is the most successful we’ve ever had,” says Dörrenberg who has now been running the company for more than 25 years.

Shampoo manufacturer Dr. Wolff initially supported the launch with one online advertisement only. “After three hours, we were already sold out online,” Dörrenberg states. According to the Managing Partner, the willingness of all the retailers involved to ramp up stocks immediately was remarkable. Currently, supply chain management is thus working intensively to prevent supply bottlenecks during the upcoming TV campaigns, especially since the product became the top-selling shampoo in the German drugstore market after just four weeks as well as bestseller in the entire beauty category on Amazon.

Dr. Wolff research reaches a further milestone in the field of oral care 

A recently published long-term study conducted under highest scientific standards, in which adult participants brushed their teeth for 18 months with either hydroxyapatite toothpaste or fluoride toothpaste, provides renewed evidence of the efficacy of hydroxyapatite. Results show that the active ingredient hydroxyapatite (HAP) and commonly used fluoride are equally effective in cavity prophylaxis. This is an important result for Dr. Wolff as the company uses the natural active ingredient HAP as a modern alternative in all its dental care products, generating a 15 percent increase in sales in this segment.

“We are continuing to invest in research and innovative products and are thus consistently pursuing our Dr. Wolff course,” the entrepreneur states. In addition, there is also very good news from Berlin for people who sweat excessively. After a one-year introductory phase for Axhidrox®, a cream to combat heavy underarm sweating, an agreement has been achieved with the German Federal Association of Statutory Health Insurance Funds for the permanent reimbursement of the anticholinergic pharmaceutical.

Expansion of the management board

On September 1, 2023, Dr. Andreas Brinkhoff (45) will strengthen the management of the Dr. Wolff Group as the fourth member with responsibility for supply chain and IT, paving the way for the organization’s future. This will result in the following areas of responsibility: Dr. Christian Mestwerdt will continue to be responsible for Finance, Controlling, Administration and Regulatory Affairs. Managing Partner Christoph Harras-Wolff will be responsible for Legal Affairs, Associations and Sustainability. Managing Partner Eduard R. Dörrenberg will be responsible for Research and Development, Marketing, Sales as well as Human Resources and took over as Chairman of the Management Board in April.